Advancements in CLL Treatment

This chapter explores significant progress in chronic lymphocytic leukemia (CLL) treatments, highlighting the impact of novel therapies like BTK inhibitors on patient life expectancy. It discusses the historical context, recent clinical trials, and future strategies including MRD monitoring and immune therapy integration for better patient outcomes.